These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 1164252)

  • 1. Bilirubin as a cholestatic agent. III. Prevention of bilirubin-related cholestasis by sulfobromophthalein.
    Witzleben CL; Boyce WH
    Arch Pathol; 1975 Sep; 99(9):492-5. PubMed ID: 1164252
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bilirubin as a cholestatic agent. IV. Effect of bilirubin and sulfobromophthalein (BSP) on biliary manganese excretion.
    Witzleben CL; Boyce WH
    Arch Pathol; 1975 Sep; 99(9):496-8. PubMed ID: 1164253
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bilirubin excretion pattern in manganese-bilirubin cholestasis.
    de Lamirande E; Plaa GL
    Arch Int Pharmacodyn Ther; 1979 May; 239(1):24-35. PubMed ID: 485717
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Functional changes of the biliary tree associated with experimentally induced cholestasis: sulfobromophthalein on manganese-bilirubin combinations.
    Dahlström-King L; Couture J; Plaa GL
    Toxicol Appl Pharmacol; 1991 May; 108(3):559-67. PubMed ID: 1902335
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bilirubin as a cholestatic agent. II. Effect of variable doses of bilirubin on the severity of manganese-bilirubin cholestasis.
    Boyce W; Witzleben CL
    Am J Pathol; 1973 Sep; 72(3):427-32. PubMed ID: 4728892
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reversible impairment of neonatal hepatobiliary function by maternal cholestasis.
    Monte MJ; Morales AI; Arevalo M; Alvaro I; Macias RI; Marin JJ
    Hepatology; 1996 May; 23(5):1208-17. PubMed ID: 8621155
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cholestasis induced by sodium taurolithocholate in isolated hamster liver.
    King JE; Schoenfield LJ
    J Clin Invest; 1971 Nov; 50(11):2305-12. PubMed ID: 5096514
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bilirubin as a cholestatic agent. Physiologic and morphologic observations.
    Witzleben CL
    Am J Pathol; 1971 Feb; 62(2):181-94. PubMed ID: 5540657
    [No Abstract]   [Full Text] [Related]  

  • 9. Maximal hepatic bilirubin transport in the rat during somatostatin-induced cholestasis and taurocholate-choleresis.
    Ricci GL; Cornelis M; Fevery J; De Groote J
    J Lab Clin Med; 1983 Jun; 101(6):835-46. PubMed ID: 6133900
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Shared and separate pathways for biliary excretion of bilirubin and BSP in rats.
    Clarenburg R; Kao CC
    Am J Physiol; 1973 Jul; 225(1):192-200. PubMed ID: 4714401
    [No Abstract]   [Full Text] [Related]  

  • 11. Comparison of sulfobromophthalein (BSP) and sulfobromophthalein glutathione (BSP-GSH) disposition under conditions of altered liver function and in the isolated perfused rat liver.
    Yam J; Reeves M; Roberts RJ
    J Lab Clin Med; 1976 Mar; 87(3):373-83. PubMed ID: 1249471
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The handling of bilirubin and sulfobromophthalein by the isolated perfused rat liver.
    Céspedes JM; Rodríguez Garay EA
    Acta Physiol Lat Am; 1979; 29(4-5):217-22. PubMed ID: 263171
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of bilirubin ditaurate overload on canalicular membrane function and ultrastructure of the pig liver.
    Labori KJ; Lyberg T; Raeder MG
    Injury; 2009 Aug; 40(8):868-72. PubMed ID: 19376516
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reversible cholestasis induced by bromosulfophthalein in rabbits with enterohepatic circulation of bile acids maintained.
    Jiménez R; Larrubia O; Monte MJ; Gonzalez J; Esteller A
    Biomed Biochim Acta; 1988; 47(2):141-7. PubMed ID: 2845961
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impaired activity of the bile canalicular organic anion transporter (Mrp2/cmoat) is not the main cause of ethinylestradiol-induced cholestasis in the rat.
    Koopen NR; Wolters H; Havinga R; Vonk RJ; Jansen PL; Müller M; Kuipers F
    Hepatology; 1998 Feb; 27(2):537-45. PubMed ID: 9462655
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Physiologic and morphologic natural history of a model of intrahepatic cholestasis (manganese-bilirubin overload).
    Witzleben CL
    Am J Pathol; 1972 Mar; 66(3):577-88. PubMed ID: 5060584
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Galactosamine prevents ethinylestradiol-induced cholestasis.
    Crocenzi FA; Pellegrino JM; Catania VA; Luquita MG; Roma MG; Mottino AD; Pozzi EJ
    Drug Metab Dispos; 2006 Jun; 34(6):993-7. PubMed ID: 16554370
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Multicompartmental analysis of 2- and 3 exponential plasma disapperance curves following single i.v. injection of C14-cholic acid, bromosulfophthalein and 14C-bilirubin and their importance for quantitative studies of the excretory liver function].
    Klapdor R; Eppers J
    Z Gastroenterol; 1974 Feb; 12(1):1-8. PubMed ID: 4440041
    [No Abstract]   [Full Text] [Related]  

  • 19. Effects of diosgenin, a plant-derived steroid, on bile secretion and hepatocellular cholestasis induced by estrogens in the rat.
    Accatino L; Pizarro M; Solís N; Koenig CS
    Hepatology; 1998 Jul; 28(1):129-40. PubMed ID: 9657105
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hepatic subcellular distribution of manganese in manganese and manganese-bilirubin induced cholestasis.
    Ayotte P; Plaa GL
    Biochem Pharmacol; 1985 Nov; 34(21):3857-65. PubMed ID: 4062960
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.